Foreword | p. ix |
Abbreviations | p. xi |
Introduction | |
How to use this book | p. 3 |
Basic concepts in the epidemiology and control of infectious disease | p. 5 |
Health protection on-call | p. 10 |
Common topics | |
Meningitis and meningism | p. 17 |
Gastrointestinal infection | p. 20 |
Community-acquired pneumonia | p. 28 |
Rash in pregnancy | p. 29 |
Rash and fever in children | p. 34 |
Illness in returning travellers | p. 37 |
Sexually transmitted infections | p. 38 |
Jaundice | p. 42 |
Infection in the immunocompromised | p. 43 |
Blood-borne viral infections | p. 45 |
Vaccine queries | p. 49 |
Diseases | |
Amoebic dysentery | p. 55 |
Anthrax | p. 56 |
Bacillus cereus | p. 59 |
Botulism | p. 60 |
Brucellosis | p. 65 |
Campylobacter | p. 67 |
Chickenpox and shingles (varicella-zoster infections) | p. 71 |
Chlamydia pneumoniae | p. 73 |
Chlamydia psittaci | p. 75 |
Chlamydia trachomatis (genital) | p. 77 |
Cholera | p. 78 |
CJD (Creutzfeldt-Jakob disease) and other human transmissible spongiform encephalopathies | p. 80 |
Clostridium difficile | p. 82 |
Clostridium perfringens | p. 84 |
Coxsackievirus infections | p. 86 |
Cryptosporidiosis | p. 88 |
Cyclosporiasis | p. 93 |
Cytomegalovirus | p. 93 |
Dengue fever | p. 94 |
Diphtheria | p. 95 |
Encephalitis, acute | p. 98 |
Enterococci, including glycopeptide-resistant enterococci | p. 98 |
Epstein-Barr virus | p. 100 |
Escherichia coli O157 (and other E. coli gastroenteritis) | p. 101 |
Giardiasis | p. 106 |
Gonorrhoea, syphilis and other acute STIs | p. 108 |
Hantavirus | p. 111 |
Head lice | p. 112 |
Helicobacter pylori | p. 114 |
Hepatitis A | p. 115 |
Hepatitis B | p. 118 |
Hepatitis C | p. 122 |
Delta hepatitis | p. 125 |
Hepatitis E | p. 125 |
Herpes simplex | p. 126 |
Haemophilus influenzae type b | p. 127 |
HIV | p. 129 |
Influenza | p. 135 |
Japanese B encephalitis | p. 141 |
Kawasaki syndrome | p. 141 |
Legionellosis | p. 142 |
Leprosy | p. 145 |
Leptospirosis | p. 146 |
Listeria | p. 148 |
Lyme disease | p. 150 |
Malaria | p. 151 |
Measles | p. 154 |
Meningococcal infection | p. 156 |
Molluscum contagiosum | p. 161 |
MRSA (methicillin-resistant Staphylococcus aureus) | p. 162 |
Mumps | p. 165 |
Mycoplasma | p. 166 |
Norovirus | p. 168 |
Ophthalmia neonatorum | p. 170 |
Paratyphoid fever | p. 171 |
Parvovirus B19 (fifth disease) | p. 173 |
Plague | p. 174 |
Pneumococcal infection | p. 176 |
Poliomyelitis | p. 179 |
Q fever | p. 180 |
Rabies | p. 182 |
Relapsing fever | p. 184 |
Respiratory syncytial virus | p. 185 |
Ringworm | p. 187 |
Rotavirus | p. 190 |
Rubella | p. 192 |
Salmonellosis | p. 193 |
SARS (Severe acute respiratory syndrome) | p. 197 |
Scabies | p. 200 |
Shigella | p. 203 |
Smallpox | p. 206 |
Staphylococcal food poisoning | p. 208 |
Streptococcal infections | p. 209 |
Tetanus | p. 212 |
Threadworms | p. 213 |
Tick-borne encephalitis | p. 214 |
Toxocara | p. 214 |
Toxoplasmosis | p. 215 |
Tuberculosis | p. 216 |
Tularaemia | p. 225 |
Typhoid fever | p. 226 |
Typhus, other rickettsial infections and ehrlichiosis | p. 228 |
Vibrio parahaemolyticus | p. 230 |
Viral haemorrhagic fevers | p. 232 |
Warts and verrucae | p. 235 |
West Nile virus | p. 236 |
Whooping cough | p. 237 |
Yellow fever | p. 240 |
Yersiniosis | p. 241 |
Other hazards | p. 243 |
Helminths | p. 243 |
Protozoa | p. 251 |
Fungi | p. 251 |
Rare viruses | p. 251 |
Bites, stings and venoms | p. 251 |
Chemical food-borne illness | p. 263 |
Services and organisations | |
Administrative arrangements for communicable disease control | p. 267 |
Surveillance of communicable disease | p. 271 |
Managing infectious disease incidents and outbreaks | p. 275 |
Community infection control | p. 282 |
Healthcare-associated infection | p. 285 |
Risks to and from healthcare workers | p. 290 |
Co-ordination of immunisation services | p. 295 |
Co-ordination of services for HIV infection in the UK | p. 298 |
Services for tuberculosis control | p. 299 |
Travel health and illness in returning travellers | p. 302 |
Non-infectious environmental hazards | p. 305 |
Managing acute chemical incidents | p. 310 |
Managing acute radiation incidents | p. 313 |
Deliberate release of biological, chemical or radiological agents | p. 315 |
Port health | p. 324 |
Media relations | p. 325 |
Clinical governance and audit | p. 327 |
Communicable disease control in Europe | |
Introduction | p. 333 |
Austria | p. 335 |
Belgium | p. 336 |
Cyprus | p. 339 |
Czech Republic | p. 340 |
Denmark | p. 342 |
Estonia | p. 344 |
Finland | p. 345 |
France | p. 347 |
Germany | p. 349 |
Greece | p. 351 |
Hungary | p. 352 |
Ireland | p. 353 |
Italy | p. 354 |
Latvia | p. 356 |
Lithuania | p. 358 |
Luxembourg | p. 358 |
Malta | p. 360 |
The Netherlands | p. 361 |
Norway | p. 363 |
Poland | p. 364 |
Portugal | p. 366 |
Slovakia | p. 368 |
Slovenia | p. 369 |
Spain | p. 371 |
Sweden | p. 372 |
Switzerland | p. 374 |
United Kingdom | p. 376 |
Appendices | |
Useful addresses and telephone numbers | p. 379 |
Guidance documents and books | p. 380 |
Index | p. 385 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.